Enzymatic strategies to detoxify gluten: Implications for celiac disease

Enzyme Research

Volumn 2010, Issue , 2010, Pages

  Caputo, Ivana ^a,b   Lepretti, Marilena ^a   Martucciello, Stefania ^a   Esposito, Carla ^a,b  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 BIOTINAMIDOPENTYLAMINE; ANTIBODY; BACTERIUM ENDOPEPTIDASE; CYSTAMINE; DANSYLCADAVERINE; ENZYME; ENZYME INHIBITOR; EP B2; EPITOPE; FOOD ADDITIVE; GASTROINTESTINAL AGENT; GLIADIN; GLUTAMINE SPECIFIC ENDOPROTEASE; GLUTEN; INTERLEUKIN 10; INTERLEUKIN 15 ANTIBODY; LACTOBACILLUS DERIVED PEPTIDASE; LARAZOTIDE; PENTYLAMINE; PROBIOTIC AGENT; PROLYL ENDOPEPTIDASE; PROLYL SPECIFIC ENDOPEPTIDASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PUTRESCINE; SYNTHETIC POLYMERIC BINDER; TRANSGLUTAMINASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VSL3;

AGGLUTINATION TEST; AMINO ACID COMPOSITION; ASPERGILLUS NIGER; AUTOIMMUNITY; BARLEY; CELIAC DISEASE; CHRYSEOBACTERIUM MENINGOSEPTICUM; DEAMINATION; DETOXIFICATION; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG CAPSULE; DRUG MEGADOSE; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME THERAPY; FOOD BIOTECHNOLOGY; FOOD PROCESSING; GENETIC PREDISPOSITION; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INCIDENCE; LACTOBACILLUS; MYXOCOCCUS XANTHUS; NONHUMAN; PATHOPHYSIOLOGY; PATIENT SAFETY; PLANT BREEDING; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN PROCESSING; REVIEW; RISK REDUCTION; RYE; SPHINGOMONAS; SPHINGOMONAS CAPSULATE; SYMPTOMATOLOGY; T LYMPHOCYTE ACTIVATION; TABLET; TISSUE DISTRIBUTION; TRANSGENICS; UNSPECIFIED SIDE EFFECT; WHEAT;

HORDEUM; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 84858629754     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.4061/2010/174354     Document Type: Review

References (72)

1. Sollid L. M., Lundin K. E. A., Diagnosis and treatment of celiac disease. Mucosal Immunology 2009 2 1 3 7 2-s2.0-58049184187 10.1038/mi.2008.74
2. Tack G. J., g.tack@vumc.nl Verbeek W. H. M., Schreurs M. W. J., Mulder C. J. J., The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nature Reviews Gastroenterology and Hepatology 2010 7 4 204 213 10.1038/nrgastro.2010.23
3. Vilppula A., Kaukinen K., Luostarinen L., Krekelä I., Patrikainen H., Valve R., Mäki M., Collin P., Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterology 2009 9, article 49 2-s2.0-67651085098 10.1186/1471-230X-9-49
4. Sollid L. M., Coeliac disease: dissecting a complex inflammatory disorder. Nature Reviews Immunology 2002 2 9 647 655 2-s2.0-0036715684 10.1038/nri885 (Pubitemid 37328722)
5. Jabri B., bjabri@bsd.uchicago.edu Sollid L. M., Tissue-mediated control of immunopathology in coeliac disease. Nature Reviews Immunology 2009 9 12 858 870 10.1038/nri2670
6. Haboubi N. Y., Taylor S., Jones S., Coeliac disease and oats: a systematic review. Postgraduate Medical Journal 2006 82 972 672 678 2-s2.0-33751240826 10.1136/pgmj.2006.045443 (Pubitemid 44786875)
7. Lundin K. E. A., Nilsen E. M., Scott H. G., Loberg E. M., Gjoen A., Bratlie J., Skar V., Mendez E., Loovik A., Kett K., Oats induced villous atrophy in coeliac disease. Gut 2003 52 11 1649 1652 2-s2.0-10744226363 10.1136/gut.52.11.1649 (Pubitemid 37363452)
8. Norris J. M., Barriga K., Hoffenberg E. J., Taki I., Miao D., Haas J. E., Emery L. M., Sokol R. J., Erlich H. A., Eisenbarth G. S., Rewers M., Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. Journal of the American Medical Association 2005 293 19 2343 2351 2-s2.0-20844432890 10.1001/jama.293.19.2343 (Pubitemid 40676756)
9. Ivarsson A., Hernell O., Stenlund H., Persson L. A., Breast-feeding protects against celiac disease. American Journal of Clinical Nutrition 2002 75 5 914 921 2-s2.0-0036231238 (Pubitemid 34441261)
10. Kagnoff M. F., Overview and pathogenesis of celiac disease. Gastroenterology 2005 128 4 S10 S18 2-s2.0-16244372671 10.1053/j.gastro.2005.02. 008 (Pubitemid 40460816)
11. Di Sabatino A., Corazza G. R., Coeliac disease. The Lancet 2009 373 9673 1480 1493 2-s2.0-64949090387 10.1016/S0140-6736(09)60254-3
12. Wieser H., Chemistry of gluten proteins. Food Microbiology 2007 24 2 115 119 2-s2.0-33748885488 10.1016/j.fm.2006.07.004 (Pubitemid 44428081)
13. Lagrain B., Brijs K., Delcour J. A., Reaction kinetics of gliadin-glutenin cross-linking in model systems and in bread making. Journal of Agricultural and Food Chemistry 2008 56 22 10660 10666 2-s2.0-57849160784 10.1021/jf801894r
14. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G. M., Sollid L. M., Khosla C., Structural basis for gluten intolerance in Celiac Sprue. Science 2002 297 5590 2275 2279 2-s2.0-0037183929 10.1126/science.1074129
15. Qiao S.-W., Bergseng E., Molberg O., Xia J., Fleckenstein B., Khosla C., Sollid L. M., Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. Journal of Immunology 2004 173 3 1757 1762 2-s2.0-3242801934 (Pubitemid 38971607)
16. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E. O., Schuppan D., Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Medicine 1997 3 7 797 801 2-s2.0-0030838044 10.1038/nm0797-797 (Pubitemid 27298728)
17. Lorand L., Graham R. M., Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature Reviews Molecular Cell Biology 2003 4 2 140 156 2-s2.0-0037317032 10.1038/nrm1014 (Pubitemid 36172696)
18. Molberg O., McAdam S. N., Sollid L. M., Role of tissue transglutaminase in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 2000 30 3 232 240 2-s2.0-0034120153 10.1097/00005176-200003000-00005 (Pubitemid 30366827)
19. Porta R., Gentile V., Esposito C., Mariniello L., Auricchio S., Cereal dietary proteins with sites for cross-linking by transglutaminase. Phytochemistry 1990 29 9 2801 2804 2-s2.0-0001602639
20. Esposito C., Paparo F., Caputo I., Porta R., Salvati V. M., Mazzarella G., Auricchio S., Troncone R., Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. American Journal of Gastroenterology 2003 98 8 1813 1820 2-s2.0-0042574120 10.1111/j.1572-0241.2003. 07582.x (Pubitemid 36959163)
21. Sollid L. M., Molecular basis of celiac disease. Annual Review of Immunology 2000 18 53 81 2-s2.0-0034121187 10.1146/annurev.immunol.18.1.53 (Pubitemid 30365374)
22. Nilsen E. M., Jahnsen F. L., Lundin K. E. A., Johansen F.-E., Fausa O., Sollid L. M., Jahnsen J., Scott H., Brandtzaeg P., Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998 115 3 551 563 2-s2.0-0031660029 (Pubitemid 28397290)
23. Salvati V. M., Mazzarella G., Gianfrani C., Levings M. K., Stefanile R., De Giulio B., Iaquinto G., Giardullo N., Auricchio S., Roncarolo M. G., Troncone R., Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut 2005 54 1 46 53 2-s2.0-19944368396 10.1136/gut.2003.023150 (Pubitemid 40007217)
24. Molberg O., Mcadam S. N., Körner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Norën O., Roepstorff P., Lundin K. E. A., Sjöström H., Sollid L. M., Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 1998 4 6 713 717 2-s2.0-0031779478 10.1038/nm0698-713 (Pubitemid 28274673)
25. Arentz-Hansen H., Körner R., Molberg O., Quarsten H., Vader W., Kooy Y. M. C., Lundin K. E. A., Koning F., Roepstorff P., Sollid L. M., McAdam S. N., The intestinal T cell response to α -gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Journal of Experimental Medicine 2000 191 4 603 612 2-s2.0-0034695893 10.1084/jem.191.4.603
26. Harentz-Hansen H., Mcadam S. N., Molberg O., Fleckenstein B., Lundin K. E. A., Jorgensen T. J. D., Jung G., Roepstorff P., Sollid L. M., Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002 123 3 803 809 2-s2.0-0036724918 10.1053/gast.2002.35381 (Pubitemid 34977086)
27. Shan L., Qiao S.-W., Arentz-Hansen H., Molberg O., Gray G. M., Sollid L. M., Khosla C., Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for Celiac Sprue. Journal of Proteome Research 2005 4 5 1732 1741 2-s2.0-26844558196 10.1021/pr050173t (Pubitemid 41464801)
28. Camarca A., Anderson R. P., Mamone G., Fierro O., Facchiano A., Costantini S., Zanzi D., Sidney J., Auricchio S., Sette A., Troncone R., Gianfrani C., Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. Journal of Immunology 2009 182 7 4158 4166 2-s2.0-64249115818 10.4049/jimmunol.0803181
29. Maiuri L., Troncone R., Mayer M., Coletta S., Picarelli A., De Vincenzi M., Pavone V., Auricchio S., In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. Scandinavian Journal of Gastroenterology 1996 31 3 247 253 2-s2.0-0030006037
30. Ciclitira P. J., Ellis H. J., In vivo gluten ingestion in Coeliac disease. Digestive Diseases 1998 16 6 337 340 2-s2.0-0032198071 (Pubitemid 128525939)
31. Clemente M. G., De Virgiliis S., Kang J. S., Macatagney R., Musu M. P., Di Pierro M. R., Drago S., Congia M., Fasano A., Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003 52 2 218 223 2-s2.0-0037302604 10.1136/gut.52.2.218 (Pubitemid 36115062)
32. Nikulina M., Habich C., Flohé S. B., Scott F. W., Kolb H., Wheat gluten causes dendritic cell maturation and chemokine secretion. Journal of Immunology 2004 173 3 1925 1933 2-s2.0-3242742752 (Pubitemid 38971628)
33. Barone M. V., Gimigliano A., Castoria G., Paolella G., Maurano F., Paparo F., Maglio M., Mineo A., Miele E., Nanayakkara M., Troncone R., Auricchio S., Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 2007 56 4 480 488 2-s2.0-34147212320 10.1136/gut.2005. 086637 (Pubitemid 46580502)
34. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., Londei M., m.londei@ich.ucl.ac.uk Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. The Lancet 2003 362 9377 30 37 10.1016/S0140-6736(03)13803-2 (Pubitemid 36835817)
35. Barone M. V., Zanzi D., Nanayakkara M., Cooperation between IL15 R alfa and EGFR is responsible for gliadin peptide induced and proliferation in Caco-2 cells. Proceedings of the 42nd Espghan Annual Meeting G2-02 2009
36. Errichiello S., Esposito O., oscaresp80@hotmail.com Di Mase R., Camarca M. E., Natale C., Limongelli M. G., Marano C., Coruzzo A., Lombardo M., Strisciuglio P., Greco L., Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. Journal of Pediatric Gastroenterology and Nutrition 2010 50 1 54 60 10.1097/MPG.0b013e31819de82a
37. Gallagher E., Gormley T. R., Arendt E. K., Recent advances in the formulation of gluten-free cereal-based products. Trends in Food Science and Technology 2004 15 3-4 143 152 2-s2.0-1542350800 10.1016/j.tifs.2003.09.012 (Pubitemid 38300186)
38. Hischenhuber C., Crevel R., Jarry B., Mäki M., Moneret-Vautrin D. A., Romano A., Troncone R., Ward R., Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Alimentary Pharmacology and Therapeutics 2006 23 5 559 575 2-s2.0-33645007290 10.1111/j.1365-2036.2006. 02768.x
39. Schuppan D., Junker Y., Barisani D., Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009 137 6 1912 1933 2-s2.0-70649092298 10.1053/j.gastro.2009.09.008
40. Anderson R. P., Van Heel D. A., Tye-Din J. A., Jewell D. P., Hill A. V. S., Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut 2006 55 4 485 491 2-s2.0-33645122173 10.1136/gut.2005.064550
41. Di Sabatino A., Ciccocioppo R., Cupelli F., Cinque B., Millimaggi D., Clarkson M. M., Paulli M., Cifone M. G., Corazza G. R., Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006 55 4 469 477 2-s2.0-33645118120 10.1136/gut.2005.068684
42. Sollid L. M., Khosla C., Future therapeutic options for celiac disease. Nature Clinical Practice Gastroenterology and Hepatology 2005 2 3 140 147 2-s2.0-20444489227 10.1038/ncpgasthep0111 (Pubitemid 40812513)
43. Pinier M., Verdu E. F., Nasser-Eddine M., David C. S., Vézina A., Rivard N., Leroux J., Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology 2009 136 1 288 298 2-s2.0-59849086162 10.1053/j.gastro.2008.09.016
44. Paterson B. M., Lammers K. M., Arrieta M. C., Fasano A., Meddings J. B., The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Alimentary Pharmacology and Therapeutics 2007 26 5 757 766 2-s2.0-34547852241 10.1111/j.1365-2036.2007.03413.x (Pubitemid 47246202)
45. Green P. H. R., Jabri B., Celiac disease. Annual Review of Medicine 2006 57 207 221 2-s2.0-32944469754 10.1146/annurev.med.57.051804.122404 (Pubitemid 43261988)
46. Keech C. L., Dromey J., Chen Z., Anderson R. P., McCluskey J. P., Immune tolerance induced by peptide immunotherapy in an HLA Dq2-dependent mouse model of gluten immunity. Gastroenterology 2009 136 supplement 1 A-57
47. Spaenij-Dekking L., Kooy-Winkelaar Y., Van Veelen P., Drijfhout J. W., Jonker H., Van Soest L., Smulders M. J. M., Bosch D., Gilissen L. J. W. J., Koning F., Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005 129 3 797 806 2-s2.0-24144461686 10.1053/j.gastro.2005.06.017 (Pubitemid 41242672)
48. Hamer R. J., Coeliac disease: background and biochemical aspects. Biotechnology Advances 2005 23 6 401 408 2-s2.0-22244465602 10.1016/j. biotechadv.2005.05.005 (Pubitemid 40984976)
49. Shan L., Marti T., Sollid L. M., Gray G. M., Khosla C., Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochemical Journal 2004 383 2 311 318 2-s2.0-7444226234 10.1042/BJ20040907 (Pubitemid 39446692)
50. Marti T., Molberg O., Li Q., Gray G. M., Khosla C., Sollid L. M., Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. Journal of Pharmacology and Experimental Therapeutics 2005 312 1 19 26 2-s2.0-11844263978 10.1124/jpet.104.073312 (Pubitemid 40096448)
51. Gass J., Ehren J., Strohmeier G., Isaacs I., Khosla C., Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy. Biotechnology and Bioengineering 2005 92 6 674 684 2-s2.0-28844445640 10.1002/bit.20643 (Pubitemid 41772463)
52. Mitea C., Havenaar R., Drijfhout J. W., Edens L., Dekking L., Koning F., Dekking E. H. A., Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 2008 57 1 25 32 2-s2.0-38349083815 10.1136/gut.2006.111609
53. Gass J., Bethune M. T., Siegel M., Spencer A., Khosla C., Combination enzyme therapy for gastric digestion of dietary gluten in patients with Celiac Sprue. Gastroenterology 2007 133 2 472 480 2-s2.0-34547494627 10.1053/j.gastro.2007.05.028 (Pubitemid 47187353)
54. Gobbetti M., The sourdough microflora: interactions of lactic acid bacteria and yeasts. Trends in Food Science and Technology 1998 9 7 267 274 2-s2.0-0031798042 10.1016/S0924-2244(98)00053-3 (Pubitemid 28560459)
55. Di Cagno R., De Angelis M., Lavermicocca P., De Vincenzi M., Giovannini C., Faccia M., Gobbetti M., Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Applied and Environmental Microbiology 2002 68 2 623 633 2-s2.0-0036154310 10.1128/AEM.68.2.623-633.2002 (Pubitemid 34113050)
56. Di Cagno R., De Angelis M., Auricchio S., Greco L., Clarke C., De Vincenzi M., Giovannini C., D'Archivio M., Landolfo F., Parrilli G., Minervini F., Arendt E., Gobbetti M., Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in Celiac Sprue patients. Applied and Environmental Microbiology 2004 70 2 1088 1096 2-s2.0-2342464831 10.1128/AEM.70.2.1088-1096.2004 (Pubitemid 38568235)
57. Angelis M. D., Rizzello C. G., Fasano A., Clemente M. G., Simone C. D., Silano M., Vincenzi M. D., Losito I., Gobbetti M., VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue. Biochimica et Biophysica Acta 2006 1762 1 80 93 2-s2.0-29644441042 10.1016/j.bbadis.2005.09.008 (Pubitemid 43021090)
58. Lindfors K., Blomqvist T., Juuti-Uusitalo K., Stenman S., Venäläinen J., Mäki M., Kaukinen K., Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clinical and Experimental Immunology 2008 152 3 552 558 2-s2.0-43349099918 10.1111/j.1365-2249.2008.03635.x (Pubitemid 351661494)
59. Resta-Lenert S., Barrett K. E., Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003 52 7 988 997 2-s2.0-0038460949 10.1136/gut.52.7.988 (Pubitemid 36765291)
60. Otte J.-M., Podolsky D. K., Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. American Journal of Physiology 2004 286 4 G613 G626 2-s2.0-1642274741 (Pubitemid 38374981)
61. Cinque B., Di Marzio L., Della Riccia D. N., Bizzini F., Giuliani M., Fanini D., De Simone C., Cifone M. G., Effect of Bifidobacterium infantis on interferon- γ -induced keratinocyte apoptosis: a potential therapeutic approach to skin immune abnormalities. International Journal of Immunopathology and Pharmacology 2006 19 4 775 786 2-s2.0-33846412936 (Pubitemid 46145041)
62. Yan F., Cao H., Cover T. L., Whitehead R., Washington M. K., Polk D. B., Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007 132 2 562 575 2-s2.0-33847021973 10.1053/j.gastro.2006.11.022 (Pubitemid 46274659)
63. Rizzello C. G., De Angelis M., Di Cagno R., Camarca A., Silano M., Losito I., De Vincenzi M., De Bari M. D., Palmisano F., Maurano F., Gianfrani C., Gobbetti M., Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Applied and Environmental Microbiology 2007 73 14 4499 4507 2-s2.0-34547233576 10.1128/AEM.00260-07 (Pubitemid 47122594)
64. Auricchio R., Di Mase R., Pianese A., Prolonged in vivo challenge of coeliac patients confirms reduced toxicity of gluten fermented with selected lactobacilli and fungal proteases. Proceedings of the 13th International Celiac Disease Symposium P286 2009
65. Kiyosaki T., Matsumoto I., Asakura T., Funaki J., Kuroda M., Misaka T., Arai S., Abe K., Gliadain, a gibberellin-inducible cysteine proteinase occurring in germinating seeds of wheat, Triticum aestivum L., specifically digests gliadin and is regulated by intrinsic cystatins. The FEBS Journal 2007 274 8 1908 1917 2-s2.0-34247095200 10.1111/j.1742-4658.2007.05749.x (Pubitemid 46588004)
66. Stenman S. M., Venäläinen J. I., Lindfors K., Auriola S., Mauriala T., Kaukovirta-Norja A., Jantunen A., Laurila K., Qiao S.-W., Sollid L. M., Männistö P. T., Kaukinen K., Mäki M., Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease. Annals of Medicine 2009 41 5 390 400 2-s2.0-67449099537 10.1080/07853890902878138
67. Gianfrani C., Siciliano R. A., Facchiano A. M., Camarca A., Mazzeo M. F., Costantini S., Salvati V. M., Maurano F., Mazzarella G., Iaquinto G., Bergamo P., Rossi M., Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007 133 3 780 789 2-s2.0-34548486891 10.1053/j.gastro.2007.06.023 (Pubitemid 47374136)
68. Molberg O., McAdam S., Lundin K. E. A., Kristiansen C., Arentz-Hansen H., Kett K., Sollid L. M., T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. European Journal of Immunology 2001 31 5 1317 1323 2-s2.0-0035019083 10.1002/1521- 4141(200105)31:51317::AID-IMMU1317>3.0.CO;2-I (Pubitemid 32454680)
69. Esposito C., Caputo I., Troncone R., New therapeutic strategies for coeliac disease: tissue transglutaminase as a target. Current Medicinal Chemistry 2007 14 24 2572 2580 2-s2.0-35548939047 10.2174/092986707782023343 (Pubitemid 350018470)
70. Wodzinska J. M., Transglutaminases as targets for pharmacological inhibition. Mini-Reviews in Medicinal Chemistry 2005 5 3 279 292 2-s2.0-14744294627 (Pubitemid 40331044)
71. Dolyuchuk K. N., Topical putrescine (fibrostat) in treatment of hypertrophic scars: phase II study. Plastic and Reconstructive Surgery 1996 98 4 752 2-s2.0-0029784845 (Pubitemid 26292112)
72. Hoffmann K., Alminger M., Andlid T., Chen T., Olsson O., Sandberg A.-S., Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro. Journal of Agricultural and Food Chemistry 2009 57 21 10150 10155 2-s2.0-70449120708 10.1021/jf902268z